The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 7, 2002, Pages 677-683

  Senti, Mariano ^a   Tomás, Marta ^a   Elosua, Roberto ^a   Sala, Joan ^a   Masiá, Rafel ^a   Marrugat, Jaume ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Gender; Lipids; Lipoproteins; Paraoxonase; PON1 genotypes

Indexed keywords

AMINO ACID; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; GLUCOSE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ESTERASE; PON1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CODON; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENDER; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION; POSTMENOPAUSE; PRIORITY JOURNAL; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CHOLESTEROL, LDL; CODON; ESTERASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SEX FACTORS;

EID: 0036367076     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Paraoxonase prevents accumulation of lipoperoxides in low-density lips-protein
2. Mice lacking serum paraoxonase are susceptible to organo phosphate toxicity and atherosclerosis
3. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family
4. Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins
5. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
6. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease
7. 92Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese
8. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease
9. The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary heart disease in Finns
10. The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease
11. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study
12. The Gln-Arg 192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients
13. Risk of myocardial infarction associated with Gin/Arg 192 polymorphism in human paraoxonase gene and diabetes mellitus
14. Genetic polymorphism of paraoxonase and the risk of coronary heart disease
15. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate
16. Hegele R.A. Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma in Alberta Hutterites
17. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
18. High prevalence of cardiovascular risk factor, in Gerona, Spain, a province with low myocardial infartion incidence
19. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in the province of Girona, Spain, 1990 to 1992
20. A questionnaire for the assessment of leisure time physical activities
21. Validation of the Minnesota leisure time physical activity questionnaire in Spanish men
22. Validation of the Minnesota leisure time physical activity questionnaire in Spanish women
23. Estimation of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
24. A simple salting-out procedure for extracting DNA from human nucleated cells
25. The molecular basis of the human serum paraoxonase activity polymorphism
26. Influence of serum paraoxonase polymorphism on serum lipids and lipoproteins
27. Paraoxonase polymorphism MetLeu54 is associated with modified concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
28. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus
29. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hyper-cholesterolemic patients
30. Modulated serum activities and concentrations of paraoxonase in high density lipo-protein deficiency states
31. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations
32. Differential effect of smoking on myocardial infarction risk according to the Gln/Arg variants of the human paraoxonase gene
33. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase 1 gene: The REGICOR study
34. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia
35. Paraoxonase and coronary heart disease
36. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women